Fujifilm to Invest USD 200 Million to Expand Cell Therapy Development and Manufacturing Capabilities

URLhttps://www.fujifilm.com/us/en/news/200_Million_Ce
SourceFujifilm
Date Published12/04/2023

Additional Reshoring Information:

Company/Division name FUJIFILM Cellular Dynamics, Inc.
Parent companyFUJIFILM Holdings Corporation
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2023
Year reshoring implemented or to be implemented:2026
Capital investment ($):200
Country(ies) from which reshored:Japan
City reshored to:Madison
State(s) reshored to:WI
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredexpanding cell therapy
What domestic positive factors made reshoring more attractive?Eco-system synergies
Find Reshoring Articles